Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
Recruiting · NCT07308808 · Registry updated 2025-12-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Male Urogenital Diseases, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Bladder, Neurogenic, Urogenital Diseases, central nervous system disorder, disease, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury, urinary bladder disorder, urinary system disorder, urinary tract infection | Recruiting | Early phase 1 | 2025-12-30 | NCT07308808 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Loyola University | 27 |
| Medstar Health Research Institute | 52 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MedStar National Rehabilitation Hospital | Washington D.C. | United States | 9 |